CareCloud (CCLD) AI Stock Analysis

• Market Cap: $162.52M
• Dividend Yield: N/A
• Average Volume (3M): 532.98K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.63
• Revenue Growth: 0.04%
• EPS Growth: 98.87%
• Country: US
• Employees: 3,650
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.04
• Shares Outstanding: 42,322,040
• 10 Day Avg. Volume: 1,001,643
• 30 Day Avg. Volume: 532,977
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.57
• Enterprise Value/Revenue: 0.83
• Enterprise Value/Gross Profit: 1.93
• Enterprise Value/Ebitda: 3.68
• 1Y Price Target: $4.13
• Price Target Upside: 12.23% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 67 Neutral
• Price Target: $4.00 ▲(8.70% Upside)

CareCloud's overall stock score is driven by strong financial performance and positive earnings call highlights. However, technical analysis suggests caution due to overbought conditions, and valuation metrics are weak due to a negative P/E ratio.

Positive Factors

Acquisition Synergies

The Medsphere acquisition should provide synergies and expand CCLD's hospital presence, which had been modest.

Financial Performance

CareCloud reported 1Q25 results with revenue up 6% year-over-year, and adjusted EBITDA up 52% year-over-year, both topping expectations.

Valuation

CareCloud is trading at a lower EV/adjusted EBITDA multiple compared to peers, which indicates an attractive valuation.

Negative Factors

Dividend Obligation

The mandatory conversion of Preferred A stock improves FCF and reduces dividend obligations by over $10M.

Growth Strategy

Management plans to refocus on M&A activity as part of the growth strategy, with two small acquisitions expected to be accretive within 90 days.

Revenue Decline

Revenue declines are expected to have bottomed, with guidance calling for modest growth in 2025.

CareCloud Business Overview & Revenue Model

Company Description

CareCloud (CCLD) is a leading provider of cloud-based healthcare solutions that cater to medical practices and healthcare organizations. The company operates primarily in the healthcare technology sector, offering a suite of products that includes electronic health records (EHR), practice management, revenue cycle management, and telehealth services. CareCloud's innovative platform is designed to streamline operations, enhance patient engagement, and improve overall healthcare delivery for its clients.

How the Company Makes Money

CareCloud generates revenue through a subscription-based model for its software services, which includes recurring fees for the use of its EHR and practice management solutions. Additionally, the company earns revenue from consulting services, implementation fees, and ongoing support services. Key revenue streams also include transaction-based fees from its revenue cycle management services, which are contingent on the volume of claims processed. Strategic partnerships with healthcare providers and technology companies further bolster its earnings, allowing CareCloud to expand its market reach and enhance service offerings.

CareCloud Financial Statement Overview

Summary

CareCloud's financial performance is stable with a strong balance sheet and cash flow. Despite negative revenue growth, improvements in profitability and operational efficiency are positive. Low leverage and strong cash flow provide a buffer against potential risks.

Income Statement

CareCloud's income statement shows mixed results. The TTM (Trailing-Twelve-Months) data indicates a gross profit margin of 23.58% and a net profit margin of 10.08%, which are decent but have declined from previous periods. Revenue growth is negative, indicating a contraction in sales. However, the company has managed to improve its net income and EBIT margins compared to the previous year, showing some operational efficiency improvements.

Balance Sheet

The balance sheet is relatively strong with a low debt-to-equity ratio of 0.06, indicating low leverage and financial stability. The return on equity (ROE) is healthy at 21.82%, reflecting good profitability relative to shareholder equity. The equity ratio is also strong, suggesting a solid capital structure.

Cash Flow

Cash flow analysis reveals positive trends, with a significant growth in free cash flow and a strong operating cash flow to net income ratio of 1.53. The free cash flow to net income ratio is also robust at 0.92, indicating efficient cash generation relative to net income. This suggests good liquidity and cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	111.79M	110.84M	117.06M	138.83M	139.60M	105.12M
Gross Profit	48.05M	49.99M	46.24M	54.39M	52.68M	40.30M
EBITDA	25.22M	25.05M	-31.29M	21.02M	19.22M	4.57M
Net Income	11.27M	7.85M	-48.67M	5.43M	2.84M	-8.81M
Balance Sheet
Total Assets	75.24M	71.61M	77.83M	136.17M	140.85M	138.00M
Cash, Cash Equivalents and Short-Term Investments	10.44M	5.14M	3.33M	12.30M	9.34M	20.93M
Total Debt	3.39M	3.47M	14.73M	13.81M	16.87M	11.47M
Total Liabilities	19.17M	21.84M	36.11M	34.48M	42.92M	36.75M
Stockholders Equity	56.08M	49.77M	41.72M	101.69M	97.93M	101.25M
Cash Flow
Free Cash Flow	22.38M	18.95M	3.85M	9.38M	2.77M	-8.64M
Operating Cash Flow	24.82M	20.64M	15.46M	21.15M	13.33M	-892.00K
Investing Cash Flow	-7.44M	-7.41M	-11.61M	-11.77M	-23.15M	-31.47M
Financing Cash Flow	-9.44M	-11.26M	-13.29M	-7.65M	-519.00K	33.42M

CareCloud Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3.68
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCLD, the sentiment is Positive. The current price of 3.68 is above the 20-day moving average (MA) of 2.92, above the 50-day MA of 2.61, and above the 200-day MA of 2.63, indicating a bullish trend. The MACD of 0.34 indicates Negative momentum. The RSI at 75.89 is Negative, neither overbought nor oversold. The STOCH value of 83.45 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CCLD.

CareCloud Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CCLD	67 Neutral	$162.52M	―	22.69%	―	0.04%	98.87%
FORA	52 Neutral	$61.29M	―	-3.20%	―	22.87%	-152.62%
Sector *	51 Neutral	$7.86B	-0.33	-41.39%	2.23%	23.26%	-2.03%
AMWL	50 Neutral	$111.45M	―	-38.52%	―	5.83%	61.94%
ONMD	―	$39.64M	―		―	―	―
BEAT	34 Underperform	$46.32M	―	-315.70%	―	―	-9.13%
EUDA	―	$76.54M	―		―	―	―

CareCloud Corporate Events

CareCloud Completes Acquisition of Medsphere Systems

On August 22, 2025, CareCloud, Inc. completed the acquisition of Medsphere Systems Corporation, a provider of inpatient and ambulatory solutions, thereby expanding its reach into the hospital IT market. This strategic acquisition is expected to offer affordable, scalable solutions to small and mid-sized hospitals, enhancing CareCloud’s position in the healthcare industry by integrating Medsphere’s technology with its AI capabilities to improve patient care and operational efficiency.

CareCloud Reports First Positive GAAP EPS in Q2 2025

On August 5, 2025, CareCloud announced strong financial results for the second quarter of 2025, marking its first quarter of positive GAAP EPS since going public. The company reported a GAAP net income of $2.9 million, a 73% increase from Q2 2024, and highlighted significant achievements including the launch of an AI Center of Excellence and two recent acquisitions. These strategic moves position CareCloud at the forefront of healthcare transformation, aiming for sustained profitability and long-term growth.

CareCloud Declares Dividends for Preferred Stock

On July 25, 2025, CareCloud announced that its Board of Directors declared monthly cash dividends for its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for July, August, and September 2025. This decision reflects the company’s commitment to providing returns to its shareholders and may influence its market positioning by demonstrating financial stability and shareholder value.

CareCloud Joins Russell Microcap Index Amid Stock Surge

CareCloud announced its inclusion in the Russell Microcap Index as of June 30, 2025, following a 70% rise in its common stock price during the second quarter of 2025. This milestone highlights the company’s growing momentum in the healthcare technology sector, driven by strategic initiatives such as launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position.

CareCloud Holds Annual Shareholders Meeting on May 27

CareCloud held its Annual Meeting of Shareholders on May 27, 2025, in Somerset, New Jersey, where key decisions were made regarding the company’s governance and financial oversight. During the meeting, three directors were elected to the Board, executive compensation was approved, and Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025.